Want to see GB:BSFA full AI Analyst Report?
BSFA Stock Chart & Stats
0.85 p
-0.05 p(-5.88%)
At close: 4:00 PM EDT
0.85 p
-0.05 p(-5.88%)
Day’s Range― - ―
52-Week Range0.50 p - 4.00 p
Previous CloseN/A
Volume840.17K
Average Volume (3M)374.14K
Market Cap
£1.65M
Enterprise Value-136.50K
Total Cash (Recent Filing)£60.17K
Total Debt (Recent Filing)£482.32K
Price to Earnings (P/E)―
Beta3.74
Next Earnings
Feb 04, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding193,749,440
10 Day Avg. Volume343,597
30 Day Avg. Volume374,142
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.46
Price to Sales (P/S)75.11
P/FCF Ratio-3.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe company has demonstrated strong top-line expansion from 2023 to 2025, with triple-digit growth in 2025. Sustained revenue scaling provides a foundation for future operating leverage and margin recovery if the firm can maintain growth while controlling costs over the next several quarters.
Low Leverage / Balance Sheet FlexibilityZero reported debt materially reduces default and interest-rate risk, preserving financial flexibility. For a cash-burning biotech, low leverage eases near-term refinancing pressure and allows management to pursue R&D or commercialization choices without immediate debt servicing constraints.
Improving Operating Cash BurnYear-over-year improvement in operating cash outflows signals better expense control or initial scaling benefits. If this trend persists, it reduces funding needs and strengthens sustainability prospects, giving management more time to reach break-even or reduce reliance on dilutive financing.
Bears Say
Persistent UnprofitabilityNegative gross profit and recurring large losses indicate the core business model isn't covering direct costs. Over a multi-quarter horizon, persistent unprofitability risks further equity erosion, forces strategic trade-offs, and necessitates material margin improvement or new revenue streams to reach sustainable profitability.
Weak Cash Generation / Falling Free Cash FlowDeclining free cash flow points to worsening funding self-sufficiency and a structural need for external financing. Overcoming a negative FCF trend is critical; otherwise the company faces recurring capital raises that can dilute shareholders and constrain long-term investment in product development or commercialization.
Eroding Equity / Negative ReturnsFalling shareholders' equity signals value erosion from continued losses and weak returns on capital. This reduces balance-sheet strength, may limit future financing options, and undermines investor confidence—challenges that can persist for multiple quarters if profitability and cashflow turnarounds are not achieved.
BSF Enterprise PLC News
BSFA FAQ
What was BSF Enterprise PLC’s price range in the past 12 months?
BSF Enterprise PLC lowest share price was 0.50 p and its highest was 4.00 p in the past 12 months.
What is BSF Enterprise PLC’s market cap?
BSF Enterprise PLC’s market cap is £1.65M.
When is BSF Enterprise PLC’s upcoming earnings report date?
BSF Enterprise PLC’s upcoming earnings report date is Feb 04, 2027 which is in 186 days.
How were BSF Enterprise PLC’s earnings last quarter?
BSF Enterprise PLC released its earnings results on Jun 30, 2026. The company reported -0.007 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.007 p.
Is BSF Enterprise PLC overvalued?
According to Wall Street analysts BSF Enterprise PLC’s price is currently Overvalued.
Does BSF Enterprise PLC pay dividends?
BSF Enterprise PLC does not currently pay dividends.
What is BSF Enterprise PLC’s EPS estimate?
BSF Enterprise PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BSF Enterprise PLC have?
BSF Enterprise PLC has 193,749,440 shares outstanding.
What happened to BSF Enterprise PLC’s price movement after its last earnings report?
BSF Enterprise PLC reported an EPS of -0.007 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BSF Enterprise PLC?
Currently, no hedge funds are holding shares in GB:BSFA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BSF Enterprise PLC
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company develops and commercializes cell-based tissue engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The principal activity of the Company is to undertake the acquisition of businesses in the biotechnology, marketing and e-commerce sectors.
Technical Analysis
Blue Star Capital
―
Braveheart Investment
―
Pires Investments
―
Primorus Investments
―
Contango Holdings Plc
―